Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study

Conclusion: Anticoagulation treatment (particularly intermediate dosage) appears to have positive impact on COVID-19 inpatients’ prognosis by inhibiting both coagulation and inflammatory cascades.

http://iv.iiarjournals.org/cgi/content/short/35/1/653?rss=1

Source: In Vivo - January 5, 2021 Category: Research Authors: POULAKOU, G., DIMAKAKOS, E., KOLLIAS, A., KYRIAKOULIS, K. G., RAPTI, V., TRONTZAS, I., THANOS, C., ABDELRASOUL, M., VANTANA, T., LEONTIS, K., KAKALOU, E., ARGYRAKI, K., BARABOUTIS, I., MICHELAKIS, E., GIAMARELLOS-BOURBOULIS, E., DIMAKOU, K., TSOUKALAS, G. Tags: Articles on Covid-19 Source Type: research